Zachary Hill MD

Dr. Zachary Hill, Ph.D. currently CSO of Soteria Biotherapeutics, a biotechnology company Zachary Hill co-founded based on technology Zachary Hill helped invent as a Postdoctoral Fellow at UCSF. At Soteria, we are using the power of protein engineering to generate best-in-class small-molecule-activated protein switches that can be used to control biological processes. We are focused on applying these switches to next-generation T-cell therapies with the goal of treating unmet needs in oncology.